6RHY

Structure of pore-forming amyloid-beta tetramers

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N TROSY	1 mM [U-15N] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		9.5	1 atm	310.15	Bruker AVANCE III 900
16	2D 1H-15N TROSY	1 mM [U-15N] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE 800
2	3D HNCA	1 mM [U-13C; U-15N; U-2H] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		9.5	1 atm	310.15	Bruker AVANCE III 900
17	3D HNCA	1 mM [U-13C; U-15N; U-2H] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE 800
3	3D HNCO	1 mM [U-13C; U-15N; U-2H] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
4	3D HN(CO)CA	1 mM [U-13C; U-15N; U-2H] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
5	3D HNCACB	1 mM [U-13C; U-15N; U-2H] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		9.5	1 atm	310.15	Bruker AVANCE III 900
18	3D HNCACB	1 mM [U-13C; U-15N; U-2H] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE 800
6	3D HN(COCA)CB	1 mM [U-13C; U-15N; U-2H] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
7	3D 13C-HMQC-[1H,1H]-NOESY-13C-HMQC	1 mM [U-13C; U-15N; U-2H] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
19	3D 13C-HMQC-[1H,1H]-NOESY-13C-HMQC	1 mM [U-13C; U-15N; U-2H] Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		9.5	1 atm	310.15	Bruker AVANCE III 900
8	3D (Hme)Cme([C]CA)CO	1 mM [U-2H,13C,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
9	3D (Hme)Cme([C]CA)NH	1 mM [U-2H,13C,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
10	3D Hme(Cme[C]CA)NH	1 mM [U-2H,13C,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
11	3D (H)C-TOCSY-C-TOCSY-(C)H	1 mM [U-2H,13C,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
12	3D Hm-CmHm NOESY	1 mM [U-2H,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
20	3D Hm-CmHm NOESY	1 mM [U-2H,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		9.5	1 atm	310.15	Bruker AVANCE III 900
13	3D Cm-CmHm NOESY	1 mM [U-2H,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
21	3D Cm-CmHm NOESY	1 mM [U-2H,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		9.5	1 atm	310.15	Bruker AVANCE III 900
14	3D Hm-NH NOESY	1 mM [U-2H,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
22	3D Hm-NH NOESY	1 mM [U-2H,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		9.5	1 atm	310.15	Bruker AVANCE III 900
15	3D Cm-NH NOESY	1 mM [U-2H,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		8.5	1 atm	310.15	Bruker AVANCE III 900
23	3D Cm-NH NOESY	1 mM [U-2H,15N]-Ile-[13CH3]d1, Ala-[13CH3], Leu/Val-[13CH3]proR Amyloid-beta A4 protein, 10 mM [U-2H] TRIS-d11, 28.5 mM [U-2H] DPC-d38	90% H2O/10% D2O		9.5	1 atm	310.15	Bruker AVANCE III 900

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	900
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
simulated annealing		CNS
simulated annealing		ARIA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	500
Conformers Submitted Total Number	15
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	ARIA		Linge, O'Donoghue and Nilges
2	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
3	data analysis	TALOS		Cornilescu, Delaglio and Bax
4	processing	TopSpin		Bruker Biospin
5	chemical shift assignment	CcpNmr Analysis		CCPN